Editorial

• Literatur

• 1 Mamawala MK, Meyer A, Landis P. et al. Utility of multiparametric MRI in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance. BJU Int 2020; [Epub ahead of print]
• 2 Washington 3rd SL, Baskin AS, Ameli N. et al. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol 2020; 2143: 574-578
• 3 Amin A, Scheltema MJ, Shnier R. et al. The Magnetic Resonance Imaging in Active Surveillance “MRIAS” Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies. J Urol 2019; [Epub ahead of print]
• 4 Kornberg Z, Cooperberg MR, Cowan JE. et al. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance. J Urol 2019; 202: 702-709